Results
94
Gain exposure to companies in the healthcare sector with a strong future outlook and robust financials.
94 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
UNH | US$513.00 | 0.6% | -4.5% | US$472.1b | US$635.85 | PE33x | E21.5% | 1.6% | ||
DXCM | US$81.07 | 1.0% | -34.6% | US$31.7b | US$96.26 | PE46.5x | E16.1% | n/a | ||
SAUH.F | US$121.05 | -2.3% | -18.9% | US$18.0b | US$140.45 | PE62.5x | E21.2% | 0.8% | ||
SAUH.Y | US$12.19 | -3.3% | -19.5% | US$18.0b | US$14.14 | PE62.5x | E21.2% | 0.8% | ||
PMCU.F | US$155.27 | -1.7% | 139.8% | US$26.5b | US$115.44 | PE319.8x | E21.0% | 0.2% | ||
FSPK.F | US$25.91 | 0% | n/a | US$22.3b | US$22.81 | PE124.8x | E24.1% | 1.1% | ||
PMDI.Y | US$13.25 | 0% | n/a | US$13.8b | US$10.59 | PE197.4x | E18.6% | 0.3% | ||
PEN | US$241.97 | 0.9% | 4.4% | US$9.3b | US$259.40 | PE268.8x | E35.4% | n/a | ||
HSIC | US$69.09 | -1.9% | -6.5% | US$8.6b | US$74.83 | PE27.4x | E26.7% | n/a | ||
HQY | US$97.47 | 1.2% | 43.4% | US$8.4b | US$113.00 | PE87.4x | E39.6% | n/a | ||
INSP | US$198.68 | 5.4% | 13.1% | US$6.0b | US$239.60 | PE180.2x | E31.3% | n/a | ||
HIMS | US$26.63 | 0.3% | 218.9% | US$5.8b | US$25.21 | PE57.5x | E14.3% | n/a | ||
YPHD.F | US$409.71 | 0% | n/a | US$4.6b | US$509.11 | PE62x | E40.1% | 0.6% | ||
AMBF.F | US$19.90 | 0% | 39.0% | US$27.7b | US$24.42 | PE117.9x | E27.0% | 0.4% | ||
AMBB.Y | US$13.02 | 0% | -9.9% | US$28.0b | US$15.81 | PE119.2x | E27.0% | 0.4% | ||
BTSG | US$17.64 | 3.6% | n/a | US$3.1b | US$21.50 | PS0.3x | E56.2% | n/a | ||
NARI | US$49.77 | -6.0% | -22.3% | US$2.9b | US$66.59 | PS5.1x | E66.1% | n/a | ||
SIGG.F | US$1.86 | 0% | n/a | US$4.4b | US$1.34 | PS1.3x | E36.9% | 0.4% | ||
SGRY | US$21.08 | 0.7% | -32.1% | US$2.7b | US$33.52 | PS0.9x | E83.3% | n/a | ||
PRVA | US$19.96 | 0.6% | -6.2% | US$2.4b | US$26.14 | PE186.8x | E34.2% | n/a | ||
ARDT | US$16.64 | -1.6% | n/a | US$2.4b | US$22.60 | PE25.8x | E38.8% | n/a | ||
TGLV.Y | US$0.91 | -21.7% | 12.3% | US$10.7b | US$0.81 | PS3.7x | E67.4% | 0% | ||
TPGV.F | US$0.31 | 0% | 64.5% | US$10.7b | US$0.28 | PS3.7x | E67.4% | 0% | ||
MEDG.F | US$83.91 | 0% | n/a | US$2.0b | US$87.75 | PE43.2x | E21.8% | 0.5% |